Dolores Caballero Selected Research

Dolores Caballero Research Topics

Disease

21	Lymphoma (Lymphomas) 12/2021 - 01/2008
19	Neoplasms (Cancer) 10/2022 - 11/2002
18	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 07/2010
15	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 07/2002
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 04/2009
9	Bronchiolitis Obliterans Syndrome 04/2018 - 01/2006
8	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 03/2008
8	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2022 - 02/2012
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2022 - 02/2011
6	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 09/2006
6	T-Cell Lymphoma (Lymphoma, T Cell) 04/2020 - 11/2003
6	Multiple Myeloma 01/2019 - 01/2002
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2024 - 10/2010
4	Anemia 10/2019 - 10/2012
3	Pathologic Complete Response 11/2022 - 07/2010
3	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 01/2014
3	Neutropenia 10/2019 - 10/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2008
3	Exanthema (Rash) 06/2015 - 06/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2008 - 11/2005
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2022 - 01/2021
2	Infections 09/2022 - 01/2014
2	Fatigue 01/2020 - 03/2013
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2017 - 12/2014
2	Disease Progression 01/2016 - 02/2009
2	Diarrhea 06/2015 - 10/2012
2	Thrombocytopenia (Thrombopenia) 03/2013 - 10/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2007 - 11/2002
2	Hematologic Neoplasms (Hematological Malignancy) 01/2007 - 06/2003
1	Hematologic Diseases (Blood Diseases) 09/2022
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2022
1	COVID-19 12/2021
1	Communicable Diseases (Infectious Diseases) 12/2021
1	Symptom Flare Up 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Second Primary Neoplasms (Neoplasms, Second) 10/2017

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 01/2018 - 04/2005
10	fludarabineIBA 01/2017 - 04/2003
9	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 04/2003
5	romidepsin (FK228)FDA Link 12/2017 - 02/2012
5	Busulfan (Busulfex)FDA Link 10/2016 - 06/2003
4	Monoclonal AntibodiesIBA 09/2022 - 01/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017 - 06/2003
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 10/2012
3	Lenalidomide (CC 5013)FDA Link 01/2020 - 04/2016
3	Bendamustine Hydrochloride FDA Link 01/2019 - 12/2014
3	ibrutinibIBA 10/2018 - 02/2016
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 04/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017 - 01/2009
3	Vincristine (Oncovin)FDA LinkGeneric 08/2017 - 01/2009
3	ibritumomab tiuxetan (Zevalin)FDA Link 01/2017 - 03/2014
3	Bortezomib (Velcade)FDA Link 06/2015 - 10/2012
3	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 11/2002
3	Alemtuzumab (Campath)FDA Link 11/2008 - 11/2002
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 04/2020
2	mogamulizumabIBA 01/2021 - 10/2016
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 10/2013
2	temsirolimus FDA Link 12/2017 - 02/2016
2	Prednisone (Sone)FDA LinkGeneric 08/2017 - 01/2016
2	CytokinesIBA 02/2016 - 01/2006
2	Yttrium-90IBA 07/2014 - 03/2014
2	Histone Deacetylase InhibitorsIBA 01/2014 - 01/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2013 - 06/2008
2	Sirolimus (Rapamycin)FDA Link 04/2013 - 06/2007
2	14-thioglycolamido-7,8-dihydromorphinone (TAMO)IBA 02/2012 - 03/2008
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 06/2008 - 02/2008
1	ofatumumab FDA Link 01/2024
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022
1	AntibodiesIBA 09/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	GTP Phosphohydrolases (GTPases)IBA 01/2022
1	Oncogene Proteins (Oncogene Protein)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Guanosine Diphosphate (GDP)IBA 01/2022
1	Vorinostat FDA Link 01/2021
1	Aurora Kinase AIBA 10/2019
1	MLN 8237IBA 10/2019
1	Carmustine (FIVB)FDA Link 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2018
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	obinutuzumabIBA 01/2017
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2017

Therapy/Procedure

36	Therapeutics 01/2023 - 01/2007
36	Stem Cell Transplantation 11/2022 - 01/2002
17	Transplantation 12/2021 - 01/2002
13	Drug Therapy (Chemotherapy) 11/2022 - 11/2003
12	Hematopoietic Stem Cell Transplantation 11/2022 - 06/2003
7	Homologous Transplantation 01/2024 - 04/2003
7	Cell Transplantation 01/2023 - 11/2008
3	Salvage Therapy 01/2023 - 09/2013
2	Immunotherapy 12/2019 - 03/2016
2	Secondary Prevention 12/2019 - 12/2018
2	Autologous Transplantation 03/2014 - 05/2013
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013 - 10/2008
1	Radiotherapy 01/2021
1	Induction Chemotherapy 01/2020